{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:10:31Z","timestamp":1760004631186,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.diagmicrobio.2019.114962","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:40:41Z","timestamp":1575549641000},"page":"114962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007\u20132017)"],"prefix":"10.1016","volume":"96","author":[{"given":"Andrew","family":"Walkty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather J.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denice C.","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0005","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3201\/eid2111.150750","article-title":"Fosfomycin resistance in Escherichia coli, Pennsylvania, USA","volume":"21","author":"Alrowais","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.12.008","article-title":"Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco","volume":"43","author":"Bartoloni","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S0950268816002879","article-title":"High prevalence of fosfomycin resistance gene fosA3 in blaCTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010\u20132014","volume":"145","author":"Cao","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0020","series-title":"Methods for dilution antimicrobial susceptibility tests for Bacteria that grow aerobically","volume":"M07","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0025","series-title":"Performance standards for antimicrobial susceptibility testing","volume":"M100","author":"Clinical and Laboratory Standards Institute","year":"2019"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0030","doi-asserted-by":"crossref","unstructured":"Denisuik AJ, Lagace-Wiens PRS, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, on behalf of the Canadian Antimicrobial Resistance Alliance (CARA). 2013. Molecular epidemiology of extended-spectrum \u03b2-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007\u201311. J Antimicrob Chemother 68 Suppl 1:i57-i65.","DOI":"10.1093\/jac\/dkt027"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jgar.2018.01.015","article-title":"Draft genome sequence of a CTX-M-8, CTX-M-55 and FosA3 co-producing Escherichia coli ST117\/B2 isolated from an asymptomatic carrier","volume":"12","author":"Fernandes","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0045","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0050","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0055","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dks465","article-title":"Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin","volume":"68","author":"Hou","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jac\/dkx389","article-title":"Origin of the plasmid-mediated fosfomycin resistance gene fosA3","volume":"73","author":"Ito","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","article-title":"Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in gram-negative pathogens","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0070","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0075","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkx489","article-title":"Emergency of blaCTX-M-55 associated with fosA, rmtB and mcr gene variants in Escherichia coli from various animal species in France","volume":"73","author":"Lupo","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/ice.2017.156","article-title":"Incidence of extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review","volume":"38","author":"McDanel","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3201\/eid2202.151301","article-title":"Importation of fosfomycin resistance fosA3 gene to Europe","volume":"22","author":"Mendes","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jgar.2018.10.025","article-title":"Pandemic Escherichia coli ST648 isolate harboring fosA3 and blaCTX-M-8 on an IncI1\/ST113 plasmid: a new successful combination for the spread of fosfomycin resistance?","volume":"15","author":"Palmeira","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0095","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.01834-09","article-title":"2010. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes","volume":"54","author":"Wachino","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0100","doi-asserted-by":"crossref","unstructured":"Wang XM, Dong Z, Schwarz S, Zhu Y, Hau X, Zhang Y, Liu S, Zhang WJ. 2017. Plasmids of diverse Inc groups disseminate the fosfomycin resistance gene fosA3 among Escherichia coli isolates from pigs, chickens, and dairy cows in Northeast China. Antimicrob Agents Chemother 61:e00859\u201317.","DOI":"10.1128\/AAC.00859-17"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmii.2017.10.006","article-title":"Update on fosfomycin-modifying genes in Enterobacteriaceae","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0110","doi-asserted-by":"crossref","first-page":"2082693","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: a first-line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114962_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnu018","article-title":"Coexistence of SFO-1 and NDM-1 \u03b2-lactamase genes and fosfomycin resistance gene fosA3 in an Escherichia coli clinical isolate","volume":"362","author":"Zhao","year":"2014","journal-title":"FEMS Microbiol Lett"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319309071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319309071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:30Z","timestamp":1760003610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319309071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0732889319309071"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114962","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007\u20132017)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114962"}}